Biospecifics Technologies Corp. (BSTC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

35 WILBUR ST LYNBROOK, NY 11563

Biospecific Tech manufactures and licenses for sale a fermentation derived enzyme named Collagenase ABC approved by the U.S. FDA for debriding chronic dermal ulcers and severely burned areas. The company is also developing additional products derived from this enzyme for potential use as pharmaceuticals.

Data as of 2019-12-02 15:03:24 -0500
Market Cap403.645 Million Shares Outstanding7.339 Million Avg 30-day Volume
P/E Ratio Dividend Yield EPS3.191
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low73.31 / 45.81 Next Earnings Date Price to Cash FLow (P/CF) 120.7227
Data provided by IEX Cloud
View SEC Filings from BSTC instead.

View recent insider trading info

Funds Holding BSTC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BSTC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GITMAN PAUL

  • Director
No longer subject to file 2020-12-02 1

SCHAMROTH MICHAEL

  • Director
No longer subject to file 2020-12-02 1

WEGMAN TOBY

  • Director
  • 10% Owner
No longer subject to file 2020-12-02 1

WEGMAN MARK N

  • Director
  • 10% Owner
No longer subject to file 2020-12-02 1

TRUITT JOSEPH CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
No longer subject to file 2020-12-02 1

SHERMAN MICHAEL A.

  • Director
No longer subject to file 2020-12-02 1

FISHMAN COREY N.

  • Director
No longer subject to file 2020-12-02 1

ENDO INTERNATIONAL PLC

  • 10% Owner
100 2020-12-02 1

CHAO JENNIFER M

  • Director
No longer subject to file 2020-12-02 1

HUTCHISON PATRICK CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2020-12-02 1

BUCHI J KEVIN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-10-23 0

CALDWELL PATRICK M PRINCIPAL FINANCIAL OFFICER

  • Officer
1,000 2019-10-01 0

MATTILA JYRKI

  • Director
376 2019-05-22 0

LAW RONALD EDWARD SVP BUSINESS DEVELOPMENT

  • Officer
0 2019-01-23 0

WEGMAN THOMAS PRESIDENT

  • Officer
  • Director
  • 10% Owner
1,238,800 2018-08-16 0

ESTATE OF EDWIN H. WEGMAN

  • 10% Owner
947,473 2016-05-18 0

VOGEL JEFFREY KENNETH

  • 5% OWNER
508,656 2015-10-28 0

LINK MAX

  • Director
0 2014-08-04 0

MORGAN HENRY

  • Director
32,193 2014-06-06 0

GOULD GEORGE M

  • Director
0 2013-09-17 0

GELLER MATTHEW

  • Director
0 2011-06-06 0

RA CAPITAL MANAGEMENT, LLC

KOLCHINSKY PETER

RA CAPITAL HEALTHCARE FUND LP

  • 10% Owner
No longer subject to file 2010-02-26 0

RA CAPITAL MANAGEMENT, LLC

KOLCHINSKY PETER

RA CAPITAL HEALTHCARE FUND LP

RA CAPITAL HEALTHCARE FUND II, L.P.

  • 10% Owner
841,603 2009-04-24 0

RA CAPITAL MANAGEMENT, LLC

ALDRICH RICHARD

KOLCHINSKY PETER

RA CAPITAL HEALTHCARE FUND LP

RA CAPITAL HEALTHCARE FUND II, L.P.

  • 10% Owner
742,196 2008-11-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments